(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1343257 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in increased expression of IER2 mRNA CTD PMID:22079256 1,1-dichloroethene increases expression EXP 6480464 vinylidene chloride results in increased expression of IER2 mRNA CTD PMID:26682919 17beta-estradiol increases expression ISO RGD:1343257 6480464 Estradiol results in increased expression of IER2 mRNA CTD PMID:19153601 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of IER2 mRNA CTD PMID:15598610 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of IER2 mRNA CTD PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of IER2 mRNA CTD PMID:21570461 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:1343257 6480464 2 more ... CTD PMID:17547211 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of IER2 mRNA CTD PMID:25172293 3-chloropropane-1,2-diol decreases expression ISO RGD:1359581 6480464 alpha-Chlorohydrin results in decreased expression of IER2 mRNA CTD PMID:28522335 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of IER2 mRNA CTD PMID:28973697 afimoxifene multiple interactions ISO RGD:1343257 6480464 GPER1 protein affects the reaction [afimoxifene results in increased expression of IER2 mRNA] CTD PMID:19153601 afimoxifene increases expression ISO RGD:1343257 6480464 afimoxifene results in increased expression of IER2 mRNA CTD PMID:19153601 aflatoxin B1 affects expression ISO RGD:1343257 6480464 Aflatoxin B1 affects the expression of IER2 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of IER2 mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of IER2 mRNA CTD PMID:16604517 amphetamine increases expression ISO RGD:1359581 6480464 Amphetamine results in increased expression of IER2 mRNA CTD PMID:30779732 antimony(0) increases expression ISO RGD:1343257 6480464 Antimony results in increased expression of IER2 mRNA CTD PMID:17547211 antirheumatic drug decreases expression ISO RGD:1343257 6480464 Antirheumatic Agents results in decreased expression of IER2 mRNA CTD PMID:24449571 arsane increases expression ISO RGD:1343257 6480464 Arsenic results in increased expression of IER2 mRNA CTD PMID:18039032 arsenic atom increases expression ISO RGD:1343257 6480464 Arsenic results in increased expression of IER2 mRNA CTD PMID:18039032 arsenous acid affects expression ISO RGD:1343257 6480464 Arsenic Trioxide affects the expression of IER2 mRNA CTD PMID:12749819 azathioprine increases expression ISO RGD:1343257 6480464 Azathioprine results in increased expression of IER2 mRNA CTD PMID:22623647 benzene decreases expression EXP 6480464 Benzene results in decreased expression of IER2 mRNA CTD PMID:15120971 , PMID:15122651 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of IER2 mRNA CTD PMID:19770486 , PMID:27195522 benzo[a]pyrene decreases methylation ISO RGD:1343257 6480464 Benzoapyrene results in decreased methylation of IER2 5' UTR, Benzoapyrene results in decreased methylation of IER2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1343257 6480464 Benzoapyrene results in increased expression of IER2 mRNA CTD PMID:26238291 , PMID:32234424 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1343257 6480464 7 more ... CTD PMID:20382639 bexarotene decreases expression ISO RGD:1343257 6480464 bexarotene results in decreased expression of IER2 mRNA CTD PMID:17178900 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of IER2 mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of IER2 mRNA CTD PMID:19850644 bisphenol A increases expression ISO RGD:1359581 6480464 bisphenol A results in increased expression of IER2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1343257 6480464 bisphenol A results in decreased expression of IER2 mRNA CTD PMID:29275510 bisphenol A affects expression ISO RGD:1359581 6480464 bisphenol A affects the expression of IER2 mRNA CTD PMID:30903817 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of IER2 mRNA CTD PMID:25594700 cadmium dichloride increases expression ISO RGD:1359581 6480464 Cadmium Chloride results in increased expression of IER2 mRNA CTD PMID:19010381 calciol decreases expression EXP 6480464 Cholecalciferol results in decreased expression of IER2 mRNA CTD PMID:16508948 carbamazepine affects expression ISO RGD:1343257 6480464 Carbamazepine affects the expression of IER2 mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of IER2 mRNA CTD PMID:25620056 chromium atom increases expression ISO RGD:1343257 6480464 Chromium results in increased expression of IER2 mRNA CTD PMID:17547211 chromium(6+) affects expression ISO RGD:1343257 6480464 chromium hexavalent ion affects the expression of IER2 mRNA CTD PMID:30690063 ciglitazone increases expression ISO RGD:1359581 6480464 ciglitazone results in increased expression of IER2 mRNA CTD PMID:22193206 cisplatin increases expression ISO RGD:1343257 6480464 Cisplatin results in increased expression of IER2 mRNA CTD PMID:24280081 cisplatin decreases expression ISO RGD:1343257 6480464 Cisplatin results in decreased expression of IER2 mRNA CTD PMID:27392435 cisplatin affects expression EXP 6480464 Cisplatin affects the expression of IER2 mRNA CTD PMID:24280081 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of IER2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IER2 mRNA] CTD PMID:17585979 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of IER2 mRNA CTD PMID:17585979 copper(II) chloride increases expression ISO RGD:1343257 6480464 cupric chloride results in increased expression of IER2 mRNA CTD PMID:17211630 copper(II) sulfate increases expression ISO RGD:1343257 6480464 Copper Sulfate results in increased expression of IER2 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1343257 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in decreased expression of IER2 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1343257 6480464 Asbestos, Crocidolite results in increased expression of IER2 mRNA CTD PMID:18687144 cyclosporin A increases expression ISO RGD:1343257 6480464 Cyclosporine results in increased expression of IER2 mRNA CTD PMID:20106945 more ... cylindrospermopsin increases expression ISO RGD:1343257 6480464 cylindrospermopsin results in increased expression of IER2 mRNA CTD PMID:24921660 diarsenic trioxide affects expression ISO RGD:1343257 6480464 Arsenic Trioxide affects the expression of IER2 mRNA CTD PMID:12749819 dibutyl phthalate increases expression ISO RGD:1359581 6480464 Dibutyl Phthalate results in increased expression of IER2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of IER2 mRNA CTD PMID:17361019 , PMID:21266533 dieldrin increases expression ISO RGD:1343257 6480464 Dieldrin results in increased expression of IER2 mRNA CTD PMID:31068361 dimethyl sulfoxide increases expression ISO RGD:1359581 6480464 Dimethyl Sulfoxide results in increased expression of IER2 mRNA CTD PMID:22193206 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO RGD:1343257 6480464 Antimony Potassium Tartrate results in increased expression of IER2 mRNA CTD PMID:17547211 dorsomorphin multiple interactions ISO RGD:1343257 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of IER2 mRNA CTD PMID:27188386 ellagic acid increases expression ISO RGD:1343257 6480464 Ellagic Acid results in increased expression of IER2 mRNA CTD PMID:12002526 Enterolactone multiple interactions ISO RGD:1343257 6480464 [Coumestrol co-treated with 2, 3-bis3'-hydroxybenzylbutyrolactone] results in decreased expression of IER2 mRNA CTD PMID:19167446 ethyl methanesulfonate decreases expression ISO RGD:1343257 6480464 Ethyl Methanesulfonate results in decreased expression of IER2 mRNA CTD PMID:23649840 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of IER2 mRNA CTD PMID:28329830 folic acid increases expression EXP 6480464 Folic Acid results in increased expression of IER2 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1343257 6480464 Formaldehyde results in increased expression of IER2 mRNA CTD PMID:28937961 glycidol decreases expression ISO RGD:1359581 6480464 glycidol results in decreased expression of IER2 mRNA CTD PMID:24915197 hydrogen peroxide affects expression ISO RGD:1343257 6480464 Hydrogen Peroxide affects the expression of IER2 mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions ISO RGD:1343257 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of IER2 protein CTD PMID:18951874 leflunomide increases expression ISO RGD:1343257 6480464 leflunomide results in increased expression of IER2 mRNA CTD PMID:28988120 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of IER2 mRNA CTD PMID:27339419 mercury dichloride increases expression ISO RGD:1359581 6480464 Mercuric Chloride results in increased expression of IER2 mRNA CTD PMID:16507785 methamphetamine increases expression ISO RGD:1359581 6480464 Methamphetamine results in increased expression of IER2 mRNA CTD PMID:19564919 methotrexate decreases expression ISO RGD:1343257 6480464 Methotrexate results in decreased expression of IER2 mRNA CTD PMID:24449571 methylisothiazolinone increases expression ISO RGD:1343257 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of IER2 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1343257 6480464 methylmercuric chloride results in increased expression of IER2 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1359581 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of IER2 mRNA CTD PMID:28801915 N-nitrosodimethylamine increases expression ISO RGD:1343257 6480464 Dimethylnitrosamine results in increased expression of IER2 mRNA CTD PMID:17547211 nickel dichloride increases expression ISO RGD:1343257 6480464 nickel chloride results in increased expression of IER2 mRNA CTD PMID:17547211 nickel sulfate increases expression ISO RGD:1343257 6480464 nickel sulfate results in increased expression of IER2 mRNA CTD PMID:16780908 oxaliplatin multiple interactions ISO RGD:1359581 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IER2 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid multiple interactions ISO RGD:1343257 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of IER2 mRNA CTD PMID:27188386 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of IER2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of IER2 mRNA] CTD PMID:17585979 paracetamol increases expression ISO RGD:1343257 6480464 Acetaminophen results in increased expression of IER2 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of IER2 mRNA CTD PMID:15606129 , PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of IER2 mRNA CTD PMID:11264010 paracetamol increases expression ISO RGD:1359581 6480464 Acetaminophen results in increased expression of IER2 mRNA CTD PMID:17202762 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1343257 6480464 perfluorooctane sulfonic acid results in increased expression of IER2 mRNA CTD PMID:27153767 phenformin decreases expression ISO RGD:1359581 6480464 Phenformin results in decreased expression of IER2 mRNA CTD PMID:31324951 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of IER2 mRNA CTD PMID:19270015 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of IER2 mRNA CTD PMID:23091169 phorbol 13-acetate 12-myristate increases expression ISO RGD:1343257 6480464 Tetradecanoylphorbol Acetate results in increased expression of IER2 mRNA CTD PMID:31068361 pirinixic acid multiple interactions ISO RGD:1343257 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of IER2 mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of IER2 mRNA CTD PMID:23811191 potassium chromate increases expression ISO RGD:1343257 6480464 potassium chromateVI results in increased expression of IER2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1343257 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in increased expression of IER2 mRNA CTD PMID:22079256 potassium dichromate increases expression ISO RGD:1343257 6480464 Potassium Dichromate results in increased expression of IER2 mRNA CTD PMID:17547211 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of IER2 mRNA CTD PMID:21278054 quercetin increases expression ISO RGD:1343257 6480464 Quercetin results in increased expression of IER2 mRNA CTD PMID:21632981 resveratrol increases expression ISO RGD:1343257 6480464 resveratrol results in increased expression of IER2 mRNA CTD PMID:12002526 rotenone increases expression ISO RGD:1359581 6480464 Rotenone results in increased expression of IER2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1343257 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of IER2 mRNA CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of IER2 mRNA CTD PMID:19073995 silver atom increases expression EXP 6480464 Silver results in increased expression of IER2 mRNA CTD PMID:27131904 silver(0) increases expression EXP 6480464 Silver results in increased expression of IER2 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:1343257 6480464 sodium arsenite results in decreased expression of IER2 mRNA CTD PMID:17879257 sodium arsenite increases expression ISO RGD:1343257 6480464 sodium arsenite results in increased expression of IER2 mRNA CTD PMID:12760830 sodium dichromate decreases expression ISO RGD:1343257 6480464 sodium bichromate results in decreased expression of IER2 mRNA CTD PMID:12760830 Soman increases expression ISO RGD:1359581 6480464 Soman results in increased expression of IER2 mRNA CTD PMID:19281266 tert-butyl hydroperoxide decreases expression ISO RGD:1343257 6480464 tert-Butylhydroperoxide results in decreased expression of IER2 mRNA CTD PMID:15336504 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of IER2 mRNA CTD PMID:31919559 theophylline multiple interactions ISO RGD:1343257 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in decreased expression of IER2 protein CTD PMID:18951874 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of IER2 mRNA CTD PMID:23557971 topotecan increases expression ISO RGD:1359581 6480464 Topotecan results in increased expression of IER2 mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:1359581 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of IER2 mRNA CTD PMID:25729387 urethane increases expression ISO RGD:1343257 6480464 Urethane results in increased expression of IER2 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1343257 6480464 Valproic Acid affects the expression of IER2 mRNA CTD PMID:25979313 valsartan multiple interactions ISO RGD:1343257 6480464 Valsartan inhibits the reaction [AGT protein results in decreased expression of IER2 mRNA] CTD PMID:19225232 vinclozolin affects expression ISO RGD:1359581 6480464 vinclozolin affects the expression of IER2 mRNA CTD PMID:19015723 vinclozolin decreases expression ISO RGD:1359581 6480464 vinclozolin results in decreased expression of IER2 mRNA CTD PMID:23034163 zinc atom multiple interactions ISO RGD:1343257 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of IER2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1343257 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of IER2 mRNA CTD PMID:18593933
